When South by Southwest held its debut festival, it was a four-day music showcase of 177 artists playing 15 venues. Thirty-five years later, it reaches way beyond music and plays out over 10 days citywide on scores of stages where it gives a preview of a future that will be funded by venture capital.
SXSW this weekend is wrapping up the 2022 edition of what has exploded into a mega-event known globally for its futuristic exploration of art, media, technology, sports, wellness, politics and activism.
A launch pad for ideas, brands and personalities that later become household names, SXSW each year draws tens of thousands of people to Austin seeking forward-thinking solutions and novel approaches to big problems.
Which is to say that the event has secured its place as a vital part of the venture capital ecosystem and its ever-optimistic quest to create the future of everything. And this year's installment has been no exception, featuring experts delving into some of Silicon Valley's biggest passion projects, from crypto and climate science to the metaverse and psychedelic drugs.
The return of SXSW following a pandemic hiatus also comes at a time when the city of Austinthanks in part to the festival itselfstars in another drama that hits home for the VC ecosystem: The rise of hot new metropolises winning over tech and other corporate leaders seeking locales that are more accommodating of their business and personal ambitions.
Conference visitors who were trying to plan out time slots in the packed schedule could be forgiven for feeling that they had to choose between equally buzzy but competing sessions: one could be about saving the world from climate change, the other about saving musicians' profits through shrewd use of NFTs and decentralized platforms.
It's a boom time in so-called Web3 innovations that empower musicians and other artists to claim economic control of their brand and intellectual property outside dominant channels owned by publishers and companies like Spotify.
Non-fungible tokens, or NFTs, created by artists are grabbing much of the spotlight, especially at music-crazy SXSW. The blockchain-based tokens can certify ownership and authenticity of digital creative assets and even physical ones (like an artist's branded merchandise). Musicians are tapping into them for a sizable revenue stream of royalty payments for sales of their branded work on secondary markets.
Kelsey Byrne, the singer-songwriter also known as Vrit, is one of them. Byrne educated herself on tokens during her own pandemic isolation and emerged with a rising name in music but also a knack for using NFTs to make a sustainable living as an indie singer. "The whole point of this is to work outside the system," she said on a panel.
Another panelist told of several artists with small followings who've been able to rack up meaningful revenue. "You can have less fans but make more money," said Sam Hysell, co-founder of digital media company NFT Now. The model is taking off. In December, investors valued NFT marketplace OpenSea at over $13 billion in a $300 million VC funding round.
Take weed. Organizers programmed at least 20 panel discussions or featured speakers on the topic as seen through issues including racial equity, regulation, consumer products, social change and international markets.
Investment in VC-backed cannabis companies retreated to $2.8 billion last year from its high point of $3.6 billion in 2019, according to PitchBook data. Investors are taking aim at the world cannabis market estimated to be worth more than $32 billion last year, mostly concentrated in North America. But opportunity for weed businesses in other world regions looms large, with 50 countries (not counting the US) having created legal cannabis markets on a national level, according to Prohibition Partners, a UK-based cannabis research firm.
"I think that provides an amazing opportunity, but it also leaves a question mark as to when the US will join the ranks," said Stephen Murphy, managing director of Prohibition Partners, who moderated a panel looking at the global pot business.
Another dozen or so other talks focused on the future (and present) of psychedelics: Psychedelics in wellness. As a market opportunity. In public policy. In tourism. Even in Judaism.
One of the best-attended panel discussions this year focused on the prospects for psychedelics to treat severe depression, PTSD and behavioral disorders. Such therapies remain on the fringes of Western medicine. But authoritative research is gaining traction, of course with Silicon Valley VC funding, among companies such as therapeutics specialist Atai Life Sciences, which is backed by Peter Thiel and recently got federal approval to do a clinical trial of a non-psychedelic form of ketamine intended for use as an antidepressant.
Another high-profile adherent is the influential entrepreneur Tim Ferriss, who took to the SXSW stage with a group of eminent psychologists to share intimate details of his experimentation with ketamine in his own battle (with "life-changing" effectiveness, by his own account) against chronic depression.
Outside the meeting hall, a passerby's T-shirt read, "Make Acid Great Again."
Regardless of how seriously you view the use of psychedelics in medicine, it's clear watching Ferriss speak that he has done his homework on the research and can hold his own delving into the scientific minutiae alongside some of the field's top experts.
Ferriss and his co-panelists like Roland Griffiths, a Johns Hopkins University pharmacology professor, said they see much promise in clinically supervised treatments through altered states of consciousness, but they also plainly acknowledged that modern medicine is in its infancy of truly understanding psychedelics.
To Pico Velasquez, a designer whose work has straddled physical and virtual dimensions, the power of the metaverse is to capture "beautiful intricacies of this world." But she also maintained it's not just about games or entertainment.
"Instead," she told one session, "it's an evolution of our lives, the future of work, the future of culture. The future of absolutely everything is going to get transported into this new space."
Some efforts to demonstrate the idea didn't quite land. At a late-night party thrown by Blockchain Creative Labs, an NFT-focused startup studio backed by Fox Entertainment, guests were invited into a pop-up exhibition that was meant to evoke the dazzling imagery associated with highly stylized digital environments. It was basically a flashy electronic installation on the walls.
At a demo kiosk for Qualcomm-owned chip designer Snapdragon, visitors could create their own digital avatars having their likeness scanned using face- and body-recognition software. My avatar, showing a fully bald man, was totally unrecognizable, but it did at least allow me to show I had a receding hairline of my own, using any color of my choosing.
Featured image of the Blockchain Creative Labs exhibit by Alexander Davis/PitchBook News
Originally posted here:
- How an NHL Enforcer Broke His Body and Turned to Psychedelics to Heal His Brain - Rolling Stone - June 22nd, 2022
- The top psychedelic drug developers leading the market - Labiotech.eu - June 22nd, 2022
- Numinus Applies for International Patent Filing of Psychedelics Production Process - Yahoo Finance - June 22nd, 2022
- Two psychedelic-related initiatives may be on the 2022 Colorado ballot - Denver 7 Colorado News - June 22nd, 2022
- Cybin Inc. Reports Fiscal Year 2022 Financial Results and Recent Business Highlights - Business Wire - June 22nd, 2022
- SPOTLIGHT IN FOCUS - The Rise of Psychedelic Therapy - Psychedelic Spotlight - June 22nd, 2022
- Rapper Vic Mensa has a more badass fitness routine than you thanks to martial arts, psychedelics and meditation - British GQ - June 22nd, 2022
- What is Ego Death And How Does it Work? - Benzinga - Benzinga - June 22nd, 2022
- Anecdotal Evidence and the Need for Trials of Psychedelics in Headache Disorders: Bryan Roth, MD, PhD - Neurology Live - June 11th, 2022
- Stephen Asma: My father's experience with morphine in hospice showed me the healing joy of altered states - Chicago Tribune - June 11th, 2022
- TDR's Top 5 Psychedelic Developments For The Week Of May 30 - The Dales Report - June 5th, 2022
- Psychedelic Wellness: 5 Magical Benefits of Magic Mushrooms - Longevity LIVE - Longevity LIVE - June 5th, 2022
- 'Magic mushrooms drug could help depression sufferers in the years to come' - Irish Mirror - June 5th, 2022
- Tripping over the potential of psychedelics for autism | Spectrum - Spectrum - June 3rd, 2022
- Can you take the trip out of psychedelics and still treat depression? - New Scientist - June 3rd, 2022
- We spark curiosity: how the psychedelics industry is taking on Davos - The Guardian - June 3rd, 2022
- Cybin Announces Publication in Frontiers in Psychology Journal Introducing EMBARK, an Integrative Model of Psychedelic Therapy - Business Wire - June 3rd, 2022
- Ketamine can treat depression but teletherapy could make it accessible - Inverse - June 3rd, 2022
- 2022-06-01 | PINL:EHVVF | Press Release | ehave Inc - Stockhouse - June 3rd, 2022
- VIDEO: The Weekly Weed Report (05-31-22) - Investing Daily - Investing Daily - June 3rd, 2022
- Psychedelics Companies in Oregon Will Have to Grapple With 280E - Business Insider - May 21st, 2022
- TDR's Top 5 Psychedelic Developments For The Week Of May 16 - The Dales Report - May 21st, 2022
- Psychedelics and Mindfulness: The Future of Mental Health? | Microdose - Microdose Psychedelic Insights - May 21st, 2022
- CATALYST Summit: 3 Psychedelic Speakers to Catch This Weekend - Psychedelic Spotlight - May 21st, 2022
- 'I took ketamine to treat my severe depression' - iNews - May 21st, 2022
- TDR's Top 5 Psychedelic Developments For The Week Of May 9 - The Dales Report - May 15th, 2022
- Psychedelic Patents are Broken Because the Patent System Is Broken - VICE - May 15th, 2022
- Magic mushrooms are on WeHos mind - WEHOville - May 15th, 2022
- Behind the Scenes on the First Study To Compare the Effects of LSD and Psilocybin - Technology Networks - May 15th, 2022
- Revitalist's Strategic Initiatives Continue to Exceed Expectations for Execution Giving Company Record High Revenues Since Opening in 2018. - Business... - May 15th, 2022
- MDMA as medicine: Stemming the tide of veteran suicides in Western North Carolina - Smoky Mountain News - May 15th, 2022
- Cybin's CYB0004 Shows Positive Preclinical Results Over ... - May 3rd, 2022
- Psychedelics played role in Wallace Falls hiker's death ... - May 3rd, 2022
- The Mainstream Healthcare VCs Dipping Their Toes Into Psychedelics - Business Insider - May 3rd, 2022
- LSD Is Back On Campus, But This Time It's Approved - Green Market Report - May 3rd, 2022
- Mixing mushrooms and alcohol: What you need to know - Medical News Today - May 3rd, 2022
- Mycotopia Therapies Partners with Public Policy Specialist PsychedelicsEUROPE to Explore Opportunities in the European Market - GlobeNewswire - May 3rd, 2022
- Pharmadrug Advances Opthalmology Program with Final Selection of Lead DMT-Analogue to Provide Sustained Control of Elevated Intraocular Pressure for... - May 3rd, 2022
- Bicycle Day: Honoring The Onset Of The Psychedelic Revolution As It Zooms Across The Globe - Forbes - April 15th, 2022
- Psilocybin Rewires the Brain for People with Depression - University of California, San Francisco - April 15th, 2022
- Field Trip Health Houston's psychedelic healing with ketamine helps patient with depressive anxiety - Houston Chronicle - April 15th, 2022
- Mental Health Week: Magnetic Stimulation, Psychedelics and Tai Chi How Treatments For Anxiety And Depression Are Growing - KPCC - April 15th, 2022
- Psychedelics Want To Win Over The Sleep Aid Market - Green Market Report - April 15th, 2022
- Terran Biosciences and Blumentech SL announce the acquisition of a patent portfolio covering the groundbreaking discoveries of prominent psychedelics... - April 15th, 2022
- Delic Labs Receives Health Canada 56 Exemption to Conduct Research on MDMA, LSD and Other Psychedelic Compounds - Yahoo Finance - April 15th, 2022
- Experts discuss the intersections of cannabis, health and food - CSU Pueblo Today - April 15th, 2022
- Psychedelics - PMC - April 11th, 2022
- Psychedelics - PubMed - April 11th, 2022
- Peace with psychedelics: Palestinians, Israelis took ayahuasca - Big Think - April 11th, 2022
- Study maps psychedelic-induced changes in consciousness to specific regions of the brain - PsyPost - April 11th, 2022
- The Next Big Addiction Treatment - The New York Times - April 11th, 2022
- SABI Mind and Reverie Psychedelics Partner To Expand Research Into Psychedelic-Assisted Therapies - Benzi - Benzinga - April 11th, 2022
- Jaden Smith on His Trippy Summer '22 Collection and the Power of Mushrooms - Complex - April 11th, 2022
- Biomind Labs to Present at Benzinga Psychedelics Capital Conference in the U.S. on April 19th 2022 - Business Wire - March 31st, 2022
- Psychedelics' Interaction With Psych Meds: More Q's Than A's - Medscape - March 31st, 2022
- The Insights Psychedelics Give You Arent Always True - March 18th, 2022
- Stage Set for Psychedelics Stock Boom: Here's Where ... - March 18th, 2022
- Jaden Smith Recalls His Experience With Psychedelic Mushrooms: Everything Just Becomes So Beautiful - Koimoi - March 18th, 2022
- Michigan Activists Submit Psychedelics Decriminalization ... - March 17th, 2022
- Psychedelics and the Future of Psychiatry - March 17th, 2022
- Mind Cure Gives Up On Psychedelics, Fires C-Suite, And Reverts To Shell After Strategic Review - The Deep Dive - March 17th, 2022
- A Fully-Seated Audience Takes Post-Punk with the Psychedelic Furs - Cornell University The Cornell Daily Sun - March 17th, 2022
- 5 people who used psychedelics to treat PTSD describe their trips - Business Insider - March 15th, 2022
- What is Microdosing, and Does it Work? - The New York Times - March 15th, 2022
- Bolt's Breslow Teams With Psychedelics Founder on Crypto Pharma Startup - The Information - March 15th, 2022
- Enveric, University of Calgary to study psychedelic therapy - OutSourcing-Pharma.com - March 15th, 2022
- Psychedelic therapy integral to ancient societies may be coming to Pennsylvania - 90.5 WESA - March 15th, 2022
- The Bluntness Debuts The BLUNTNESS/100 Its Inaugural List of the 100 Most Influential People in Cannabis & Psychedelics - 69News WFMZ-TV - March 15th, 2022
- Former NFL Player Eben Britton On His New Book, And The Tools He Used To Rebuild His Life (Including Psychedelics) - The Dales Report - March 15th, 2022
- Made by Marlo: Max Ingersoll and the Meaning of Meditation - Harvard Independent - March 15th, 2022
- What are Psychedelics? - March 8th, 2022
- Get the Legal Psychedelics for Sale in the USA ... - March 8th, 2022
- Fireside Project manifests a $200K fund to improve access to careers in psychedelic health - TechCrunch - March 8th, 2022
- Oklahoma bill to study mental health effects of 'shrooms' advances - Oklahoman.com - March 8th, 2022
- Terran Biosciences and University of Maryland, Baltimore announce exclusive licensing deal for a portfolio of patents and data supporting novel... - March 8th, 2022
- Cybin Teams With Chopra Foundation To Foster Psychedelics Awareness - Benzinga - Benzinga - March 8th, 2022
- How My Drinking Was Used to Deny Me Treatment for Depression - Filter - March 8th, 2022
- Seelos Therapeutics: Year-End Results and Business Highlights Microdose - Microdose Psychedelic Insights - March 8th, 2022
- No worries: Severe anxiety disorders to get the Incannex, Monash Uni treatment via psychedelics within vir ... - Stockhead - March 8th, 2022
- Meet the 16 Most Influential Women Shaping the Future of Psychedelics - Business Insider - February 15th, 2022